[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Aggarwal et al., 2010 - Google Patents

An overview on 5α-reductase inhibitors

Aggarwal et al., 2010

View PDF
Document ID
17291418114535448594
Author
Aggarwal S
Thareja S
Verma A
Bhardwaj T
Kumar M
Publication year
Publication venue
Steroids

External Links

Snippet

Benign prostatic hyperplasia (BPH) is the noncancerous proliferation of the prostate gland associated with benign prostatic obstruction and lower urinary tract symptoms (LUTS) such as frequency, hesitancy, urgency, etc. Its prevalence increases with age affecting around …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17

Similar Documents

Publication Publication Date Title
Aggarwal et al. An overview on 5α-reductase inhibitors
Occhiato et al. Selective non-steroidal inhibitors of 5α-reductase type 1
US4970205A (en) Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase
CA2279971C (en) Androgen synthesis inhibitors
Lombardi Exemestane, a new steroidal aromatase inhibitor of clinical relevance
Banday et al. Steroidal pyrazolines and pyrazoles as potential 5α-reductase inhibitors: Synthesis and biological evaluation
Wilson et al. Androgen physiology: unsolved problems at the millennium
CA2339368A1 (en) Inhibitors of type 3 3.alpha.-hydroxysteroid dehydrogenase
WO1989011282A1 (en) AROMATIC STEROID 5-alpha-REDUCTASE INHIBITORS
Aggarwal et al. Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: a legitimate approach
Sun et al. A review on steroidal 5α-reductase inhibitors for treatment of benign prostatic hyperplasia
SK137994A3 (en) 7-beta-substituted-4-aza-5-alpha-cholestan-ons their using for production of pharmaceutical agent and pharmaceutical agent containing them
Penning et al. Promiscuity and diversity in 3-ketosteroid reductases
JP2014094952A (en) Local active "soft" anti-androgen agent
Picard et al. Synthesis of N-substituted piperidine-4-(benzylidene-4-carboxylic acids) and evaluation as inhibitors of steroid-5α-reductase type 1 and 2
Arellano et al. New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors
Tremblay et al. Spironolactone-related inhibitors of type II 17β-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities
Aggarwal et al. Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors
Di Salle et al. Endocrine properties of the testosterone 5α-reductase inhibitor turosteride (FCE 26073)
Bratoeff et al. In vivo and in vitro effect of novel 4, 16-pregnadiene-6, 20-dione derivatives, as 5α-reductase inhibitors
Lao et al. Design, synthesis and biological evaluation of novel androst-3, 5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
Hou et al. Design and synthesis of novel steroidal imidazoles as dual inhibitors of AR/CYP17 for the treatment of prostate cancer
Bratoeff et al. Steroids with a carbamate function at C-17, a novel class of inhibitors for human and hamster steroid 5α-reductase
EP0711164B1 (en) 4-aza-pregnane 5-alpha-reductase isozyme 1 inhibitors
Bratoeff et al. Aromatic esters of progesterone as 5α-reductase and prostate growth inhibitors